NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Instruments & Supplies · USD

West Pharmaceutical Services, Inc. (WST) Stock Analysis

West Pharmaceutical Services, Inc. (WST) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

WST

$393.48

+$4.70 (+1.21%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare WST with… →

WST Key Statistics

As of Oct 21, 2026
Trading
Open
$381.98
Previous Close
$388.78
Day's Range
381.98–396.00
52-Week Range
223.83–396.00
Volume
573.69K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.13
Valuation
Market Cap
$27.69B
P/E Ratio
50.38
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
39.36
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
3.03
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
8.32
EPS (ttm)Profit attributable to each share over the last twelve months.
7.81
Financials (FY)
Revenue (FY)
$3.07B+6.25%
Net Income (FY)
$493.70M+0.20%
Profit marginThe share of revenue left as profit after all costs and taxes.
16.98%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
70.38M
1-Year Return
+41.27%
Dividend and dates
Dividend
$0.88+0.23%
Ex-Dividend Date
November 10, 2026
Earnings Date
October 29, 2026
Avg Volume
604.21K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, WST closed at $393.48, +41.27% over 1 year.

West Pharmaceutical Services, Inc. (WST) has a market capitalization of $27.69B.

In fiscal 2025, WST reported revenue of $3.07B.

WST Stock Return by Calendar Year

West Pharmaceutical Services, Inc. (WST) 10-year return: what $10,000 became

1 year
$10,000 $14,127
+41.27%
5 years
$10,000 $9,442
−5.58%
10 years
$10,000 $56,830
+468.30%

If you had invested $10,000 in West Pharmaceutical Services, Inc. (WST) 10 years ago, at the close on October 21, 2016, it would have been worth $56,830 at the close on October 21, 2026: +468.30% in total, +18.98% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+43.34%
2025−15.73%
2024−6.75%
2023+49.97%
2022−49.70%
2021+65.88%
2020+89.05%
2019+54.13%
2018−0.08%
2017+17.02%
2016 (partial year)+5.38%

As of October 21, 2026.

WST Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$3.07B$493.70M16.1%
2024$2.89B$492.70M17.0%
2023$2.95B$593.40M20.1%
2022$2.89B$585.90M20.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.07B$1.10B$636.10M$493.70M16.1%
2024$2.89B$998.50M$590.90M$492.70M17.0%
2023$2.95B$1.13B$707.40M$593.40M20.1%
2022$2.89B$1.14B$760.80M$585.90M20.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

WST Dividend History

$0.85+4.9% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.663—
2025$0.854+4.9%
2024$0.814+5.2%
2023$0.774+5.5%
YearDividends per sharePaymentsChange
2026 (partial year)$0.663—
2025$0.854+4.9%
2024$0.814+5.2%
2023$0.774+5.5%
2022$0.734+5.8%
2021$0.694+6.2%
2020$0.654+6.6%
2019$0.614+7.0%
2018$0.574+7.5%
2017$0.534—

Most recent payment: $0.22 per share, ex-dividend July 29, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

WST Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricWSTMedical Instruments & Supplies medianvs median
P/E50.3831.1962% above
P/S ratio8.322.603.2x the median
Profit margin16.98%1.62%15.4 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

West Pharmaceutical Services, Inc. (WST) is capitalised at $27.69B on the latest close. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 10,800 employees.

WST last closed at $393.48 on October 21, 2026. That is +$4.70 (+1.21%) against the previous close. The 52-week range on file runs from $223.83 to $396.00. The latest close sits 75.79% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.07B. That is +6.25% against the prior fiscal year, when revenue was $2.89B. Net income for the same year was $493.70M. That is +0.20% against the prior fiscal year. The reported profit margin is 16.98%. That is 15.4 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 7.81.

Across the 4 fiscal years on file, revenue moves from $2.89B in 2022 to $3.07B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 50.38 times earnings. That is 61.53% above the Medical Instruments & Supplies median of 31.19. On forward earnings the ratio is 39.36. The PEG ratio, which sets the P/E against expected earnings growth, reads 3.03. The price-to-sales ratio is 8.32. On price-to-sales that is 3.2 times the Medical Instruments & Supplies median of 2.6. The medians here are taken across 50 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 1.13. Daily returns over the trailing 10 years annualize to a volatility of 34.66%. Over the trailing twelve months the total return is +41.27%. Across 10 years the annualized return works out at +18.98%.

Growth & Income

Shareholders receive a dividend, yielding 0.23% on the latest price. That is 0.8 percentage points below the Medical Instruments & Supplies median yield of 1.04%. At the indicated rate that is $0.88 a share a year. The ex-dividend date on file is November 10, 2026. Dividends are recorded for 10 calendar years; 2026 shows 3 payments totalling $0.66 a share. The year before, 2025, totalled $0.85 a share.

2026 is still running; the total return is +43.34% year to date. The strongest complete calendar year on file is 2020 at +89.05%; the weakest is 2022 at −49.70%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

West Pharmaceutical Services, Inc. (WST) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
West Pharmaceutical Services, Inc. WST $27.69B 50.4
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. West Pharmaceutical Services, Inc. trades at a P/E of 50.4.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 SOLV

Solventum Corporation

$14.75B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Visit website →